Hepatitis C: how has France limited the expenses related to new treatments?. (1st November 2016)
- Record Type:
- Journal Article
- Title:
- Hepatitis C: how has France limited the expenses related to new treatments?. (1st November 2016)
- Main Title:
- Hepatitis C: how has France limited the expenses related to new treatments?
- Authors:
- Mouterde, Anne-Laure
Bocquet, François
Fusier, Isabelle
Paubel, Pascal - Abstract:
- Is Part Of:
- Expert review of pharmacoeconomics & outcomes research. Volume 16:Number 6(2016)
- Journal:
- Expert review of pharmacoeconomics & outcomes research
- Issue:
- Volume 16:Number 6(2016)
- Issue Display:
- Volume 16, Issue 6 (2016)
- Year:
- 2016
- Volume:
- 16
- Issue:
- 6
- Issue Sort Value:
- 2016-0016-0006-0000
- Page Start:
- 655
- Page End:
- 657
- Publication Date:
- 2016-11-01
- Subjects:
- HCV treatment -- viral hepatitis -- financing mechanism -- equity -- sustainability -- direct-acting antivirals -- hepatitis C
Pharmacology -- Economic aspects -- Periodicals
338.47615105 - Journal URLs:
- http://www.future-drugs.com/loi/erp ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/14737167.2016.1247696 ↗
- Languages:
- English
- ISSNs:
- 1473-7167
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3842.002996
British Library DSC - BLDSS-3PM
British Library HMNTS - Digital store
British Library HMNTS - ELD Digital store - Ingest File:
- 11189.xml